Suven Life Sciences Secures Product Patent in India and USA


December 12, 2017

Suven Life Sciences, an Indian pharmaceutical company has procured product patent each from India and the US for its drug used in treatment of disorders related with neurodegenerative diseases. The product patents are valid till 2029 and 2033 respectively.


The patented drug is expected to treat cognitive disorders including Alzheimer’s, Parkinson and Schizophrenia.